Model Number 8637-40 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Dyspnea (1816); Edema (1820); Nausea (1970); Hypervolemia (2664)
|
Event Date 09/05/2017 |
Event Type
Injury
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Information was received from a healthcare professional (hcp) via a clinical study and a manufacturer representative regarding patient receiving remodulin 10mg/ml with an unknown total dose via an implantable pump.It was reported the patient was admitted to cardiology service for overnight monitoring after a scheduled remodulin infusion pump re placement.On the morning after the replacement, the patient was noted to be up 1.5l from surgery the prior day and had increased lower extremity, nausea, and subjective dyspnea, which could be attributable to increased dose of remodulin or heart failure symptoms.The patient received 40mg iv lasix with subsequent diuresis to be net negative 1l, but still had subjective dyspnea.The event required in patient hospitalization from (b)(6) 2017.The event was reported as related to remodulin and considered serious.The outcome of the event resolved on (b)(6) 2017.The event date was (b)(6) 2017.No further complications were reported.
|
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information received from a manufacturer representative on (b)(4) 2018 indicated the diagnosis was acute volume overload.The patient's baseline weight was (b)(6) kg.No further complications were reported.
|
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information received from a healthcare provider via a clinical study reported the event was not related to the remodulin.
|
|
Search Alerts/Recalls
|